With Admelog Sanofi hopes to to turn the tables on Eli Lilly – in partnership with Boehringer Ingelheim the US pharma has stolen market share in the longer-acting insulin market with a cheaper ...

Sanofi could be "bit more" active with M&A in near future, CFO says Sanofi's R&D spending to see limited increase in 2025 Beyfortus sales double, Dupixent sales miss estimates Jan 30 - Sanofi ...

Sanofi has removed (PDF) a clutch of programs from its clinical pipeline, scratching out entries for its late-phase BTK inhibitor and phase 1 prospects linked to the multibillion-dollar takeovers ...

(RTTNews) - French drug major Sanofi (SNYNF, SNY) announced Wednesday that it has signed the share purchase agreement for the sale of a 50% controlling stake in its consumer healthcare business ...

Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...

With Admelog Sanofi hopes to to turn the tables on Eli Lilly – in partnership with Boehringer Ingelheim the US pharma has stolen market share in the longer-acting insulin market with a cheaper ...